Logistics is a key element of successful cell and gene therapy treatments. Midlands and Wales ATTC have collaborated with  GE Asymptote, completing the first logistics trial of the Chronicle software with the support of UK manufacturer Orbsen Therapeutics. Covereage of the success of this trial has been featured in Genetic Engineering and Biotechnology News, see link for more detail.